Inactive Instrument

IRRAS AB (publ) Share Price London S.E.

Equities

0GDW

SE0008321202

Medical Equipment, Supplies & Distribution

Financials

Sales 2023 * 16Cr 1.56Cr 130.6Cr Sales 2024 * 25Cr 2.36Cr 196.71Cr Capitalization 18Cr 1.72Cr 143.85Cr
Net income 2023 * -10Cr -95.74L -80Cr Net income 2024 * -2.9Cr -27.49L -23Cr EV / Sales 2023 * 2.38 x
Net Debt 2023 * 21Cr 2Cr 166.78Cr Net Debt 2024 * 26Cr 2.44Cr 204.08Cr EV / Sales 2024 * 1.77 x
P/E ratio 2023 *
-0.13 x
P/E ratio 2024 *
-0.43 x
Employees 47
Yield 2023 *
-
Yield 2024 *
-
Free-Float 3.55%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on IRRAS AB (publ)

Managers TitleAgeSince
Chief Executive Officer 49 01/18/01
Director of Finance/CFO 38 -
Director/Board Member 66 01/15/01
Members of the board TitleAgeSince
Chairman 51 01/12/01
Director/Board Member 66 01/15/01
Director/Board Member 69 01/17/01
More insiders
Irras AB is a Sweden-based medical technology company. It offers devices for fluid control and management for a broad range of brain pathologies, central nervous system (CNS) therapeutic applications and procedures. The offer comprises instruments and catheters for the clinical, monitoring and surgical applications for brain pathology indications called IRRAflow. The IRRAflow CNS System combines an External Drainage System, an intracranial pressure monitoring (ICP) Monitor and an Occlusion Solution Mechanism into a single, integrated device. The primary market for IRRAflow is the United States. The Company’s shareholders comprise Vandel Medical Equipment (CY) Limited, Serendipity Ixora AB (publ) and F.EX Endotherapy Limited, among others.
More about the company